Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS
Clinical trial NCT02933528 · COMPLETED
Trial details
- NCT number
- NCT02933528
- Sponsor
- Sun Pharmaceutical Industries, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-11
- Primary completion
- 2017-08-11
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.